Dexamethasone (DEX) Improves Functional Residual Capacity (FRC) and Respiratory Compliance (CRS) in Oxygen Dependent Very Low Birth Weight (VLBW) Infants: A Randomized, Blinded Trial. † 1072 | Zendy

AI Assistant Blog Pricing

Dexamethasone (DEX) Improves Functional Residual Capacity (FRC) and Respiratory Compliance (CRS) in Oxygen Dependent Very Low Birth Weight (VLBW) Infants: A Randomized, Blinded Trial. † 1072

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.